A real-time (PCR) for a real life - Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice
Experimental Hematology, 06/22/2012
Janikova A et al. – Pretreatment quantity of BCL2/IGH in peripheral blood (PB) or bone marrow (BM) seems to mirror the extent of disease and can provide an auxiliary prognostic parameter in Follicular lymphoma (FL). The results also support evidence of the negative prognostic value of microscopic BM involvement in FL.